Average Co-Inventor Count = 3.17
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aurigene Discovery Technologies Limited (15 from 44 patents)
2. Aurigene Oncology Limited (5 from 16 patents)
3. Auirgene Discovery Technologies Limited (1 from 1 patent)
21 patents:
1. 12268670 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents
2. 12226402 - Dual inhibitors of TIM-3 and PD-1 pathways
3. 12037321 - 1,2,4-oxadiazole derivatives as immunomodulators
4. 12005045 - Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compounds
5. 11560403 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathways
6. 11512060 - 1,2,4-oxadiazole derivatives as immunomodulators
7. 11311517 - Combination of small molecule CD-47 inhibitors with other anti-cancer agents
8. 11274123 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling
9. 10961205 - 1,2,4-oxadiazole derivatives as immunomodulators
10. 10781189 - 1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators
11. 10590093 - 1,2,4-oxadiazole derivatives as immunomodulators
12. 10173989 - 1,2,4-oxadiazole derivatives as immunomodulators
13. 10160736 - 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
14. 10106581 - Cyclic peptidomimetic compounds as immunomodulators
15. 9783578 - Immunosuppression modulating compounds